Updates.

• OCTOBER 2025

  Fund III Closes at $450M

  We are thrilled to announce the closing of Fund III, dedicated entirely to computational hardware and deep tech.

• AUGUST 2025

  Welcome Nexus Biologics

  Why we led the $4.5M seed round in Dr. Elena Rostova's revolutionary diagnostic platform.

• JANUARY 2025

  The End of the App Store Era

  A deep dive into why consumer software is no longer a viable venture scale asset class.